Johnson & Johnson (JNJ) Social Stream



Johnson & Johnson (JNJ): $182.29

2.63 (+1.46%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Johnson & Johnson (JNJ) Price Targets From Analysts

Use the tables below to see what analysts covering Johnson & Johnson think about its future price and what recommendations they have for investors and traders.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-10-21 10 $215 $175 $191.111 $177.83 7.47%
2021-12-15 10 $215 $175 $190.555 $177.83 7.16%
2022-01-26 9 $215 $175 $189.222 $177.83 6.41%
2022-01-27 9 $215 $175 $190 $177.83 6.84%
2022-03-07 10 $215 $175 $189.444 $177.83 6.53%
2022-03-16 11 $215 $175 $188.8 $177.83 6.17%

The Trend in the Analyst Price Target


Over the past 17 months, JNJ's average price target has gone up $22.81.

JNJ reports an average of 11.73% for its upside potential over the past 38 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-06-26 11 204 160 187.390 164.21 14.12%
2021-07-03 11 204 160 187.390 168.98 10.89%
2021-08-05 21 202 160 187.470 173.69 7.93%
2021-10-21 9 215 175 191.111 163.40 16.96%
2022-01-26 9 215 175 189.222 168.38 12.38%

JNJ Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
2 5 1 5 0 0 11

The Trend in the Broker Recommendations


JNJ's average broker recommendation rating worsened by 0.2 over the prior 90 days.

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • In terms of how Johnson & Johnson fares relative to Pharmaceutical Products stocks, note that its upside potential (average analyst target price relative to current price) is greater than 45.52% of that group.
  • In the context of Pharmaceutical Products stocks, Johnson & Johnson's average analyst price target is higher than 837.74% of them.
  • To contextualize these metrics, consider that out of stocks in the mega market cap category, Johnson & Johnson's variance in analysts' estimates is lower than 15.15% of them.
  • To contextualize these metrics, consider that out of stocks in the mega market cap category, Johnson & Johnson's number of analysts covering the stock is higher than 107.81% of them.

In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to Johnson & Johnson are ABT, ABBV, and TECH.

Is JNJ a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.5114 seconds.